Blog » Strategy

  • April 4, 2011 » Mainstream Media Recognizes Social Shift Towards Patient Empowerment

    By... Kristin Keller in Strategy Add Comment

    I heard a story on NPR this morning that was an incredibly moving validation of our view on how the patient-physician dynamic is changing, specifically within the rare disease space, and how empowered patients are becoming the norm. It was eerie – the piece read like a case study we would showcase. It began:
    “People who

  • December 20, 2010 » Patient-Centric Care

    By... Kristin Keller in Acquisition, Customer Targeting Add Comment

    While catching up on my plane reading today I came across the September 2010 MM&M article “GSK restructures bonuses for reps” and I was really intrigued by the incredible paradigm shift they’ve undergone at that organization.
    From the article:
    “Robert Nauman, principal at BioPharma Advisers and a former GSK marketing director, said the decision reflects the shift

  • December 7, 2010 » Meaningful Content

    By... Kristin Keller in Acquisition, Customer Targeting Add Comment

    We spend millions on market research to understand what our customers want and need. We spend millions on message testing. We spend millions on execution. But when was the last time you looked at a program and said “wow…that is rich; as a customer, I would feel fulfilled”?
    The sad reality is that, for all the

  • January 29, 2010 » HCP RM: Let’s Not Repeat The Same Mistakes

    By... Kristin Keller in HCP RM Add Comment

    As we have been discussing on our blog, many pharma companies have been contemplating the implementation of HCP RM programs, although very few have made any concrete progress. The initial steps companies have been taking are all too familiar, however, and I am concerned that the industry may follow the same path that they followed in the adoption of interactive marketing back in the late 90s/early 2000s.

Subscribe
RECENT POSTS
Compass is a proud sponsor of the World Orphan Drug Congress in Washington, DC April 11-13